Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/09/2007 | US20070186289 Animal model for HIV induced disease |
08/09/2007 | US20070185321 Growth differentiation factor-8 |
08/09/2007 | US20070185320 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response |
08/09/2007 | US20070185319 Radionally designed siRNA; duplex region comprises a sense region and an antisense region |
08/09/2007 | US20070185318 siRNA targeting connexin 43 |
08/09/2007 | US20070185317 siRNA targeting HtrA serine peptidase 1 |
08/09/2007 | US20070185313 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
08/09/2007 | US20070185312 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
08/09/2007 | US20070185050 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene |
08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
08/09/2007 | US20070185047 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/09/2007 | US20070185046 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/09/2007 | US20070185044 Inhibiting SARS virus infection or replication in cell or tissue by contacting cell or tissue with an antisense compound 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding ACE2, wherein compound is specifically hybridizable with nucleic acid molecule encoding ACE2 |
08/09/2007 | US20070185043 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina) |
08/09/2007 | US20070185042 Sirna based methods for treating alzheimer's disease |
08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
08/09/2007 | US20070184540 Metabolically engineered bacterial strains having enhanced 2-keto-D-gluconate accumulation |
08/09/2007 | US20070184538 Mortierella alpina lysophosphatidic acid acyltransferase homolog for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
08/09/2007 | US20070184534 Microbial production of l-ascorbic acid |
08/09/2007 | US20070184532 Method for Producing L-Histidine Using Bacteria of Enterobacteriaceae Family |
08/09/2007 | US20070184531 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
08/09/2007 | US20070184528 Induction and stabilization of enzymatic activity in microorganisms |
08/09/2007 | US20070184527 Methods for Production of Proteins |
08/09/2007 | US20070184525 Method of producing proteins |
08/09/2007 | US20070184524 Isolated nucleic acids, polypeptides, host cells, and methods and materials for producing 3-hydroxypropionic acid |
08/09/2007 | US20070184521 Novel phytase and gene |
08/09/2007 | US20070184520 Reduction of spontaneous mutation rates in cells |
08/09/2007 | US20070184513 Substrates for beta-lactamase and uses thereof |
08/09/2007 | US20070184484 Anti-abnormal type prion monoclonal antibody, process for producing the same, and immunoassay of abnormal type prion protein using the same |
08/09/2007 | US20070184482 Methods of Random Mutagenesis and Methods of Modifying Nucleic Acids Using Translesion DNA Polymerases |
08/09/2007 | US20070184475 Sequence determination by direct detection |
08/09/2007 | US20070184471 Analyte assay using particulate labels |
08/09/2007 | US20070184470 Method to measure gene expression ratio of key genes |
08/09/2007 | US20070184465 Methods for regulating hematopoiesis using CpG-oligonucleotides |
08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
08/09/2007 | US20070184459 Methods of inhibiting cancer growth by binding to nuclear receptors |
08/09/2007 | US20070184453 Fret process |
08/09/2007 | US20070184451 Compounds and methods for molecular biology |
08/09/2007 | US20070184446 Method of stretching single-stranded nucleic acid, single-stranded nucleic acid stretching system and dna chip |
08/09/2007 | US20070184442 Lafora's disease gene |
08/09/2007 | US20070184074 Fusion proteins of Mycobacterium tuberculosis |
08/09/2007 | US20070184073 TB diagnostic based on antigens from M. tuberculosis |
08/09/2007 | US20070184070 Recombinant toxin fragments |
08/09/2007 | US20070184069 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
08/09/2007 | US20070184057 Use of weak stressors to enhance the effectiveness of ionizing radiation and other treatments of disease |
08/09/2007 | US20070184056 Use of weak stressors to enhance the effectiveness of ionizing radiation and other treatments of disease |
08/09/2007 | US20070184028 preparation comprising the vector system of the invention and an interfering agent; treatment of hemophilia, diabetes, rheumatoid arthritis, genetic immunodeficiency, and graft versus host disease |
08/09/2007 | US20070184027 Evacuating a clot from a blood vessel in a mammal; isolating a segment around evacuation site; infecting a segment of a blood vessel in vitro using a gutless adenoviral vector comprising a polynucleotide encoding a thrombomodulin protein or its variant; grafting the virus-treated blood vessel in mammal |
08/09/2007 | US20070184026 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
08/09/2007 | US20070184025 Chimaeric vector system |
08/09/2007 | US20070184023 Method for down-regulation of vegf |
08/09/2007 | US20070183975 Polypeptide absorbable into digestive organs |
08/09/2007 | US20070183970 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
08/09/2007 | US20070181482 Mechanism of separating and purifying dna and the like |
08/09/2007 | DE20122767U1 Massives Parallelverfahren zur Dekodierung von DNA und RNA Massive parallel method for decoding DNA and RNA |
08/09/2007 | DE102006011918A1 New recombinant nucleic acid, useful for controlled expression of foreign sequences, includes a regulatory unit, the tet-operator and an independent origin of replication |
08/09/2007 | CA2641410A1 Genes for prognosis of cancer |
08/09/2007 | CA2641303A1 Na/k-atpase ligand |
08/09/2007 | CA2641226A1 Soybean isopentenyl transferase genes and methods of use |
08/09/2007 | CA2641219A1 Alpha-synuclein kinase |
08/09/2007 | CA2640661A1 Domain antibody construct |
08/09/2007 | CA2640614A1 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential |
08/09/2007 | CA2640528A1 Oncolytic adenoviruses for cancer treatment |
08/09/2007 | CA2640458A1 Lipoparticles comprising ion channels, methods of making, and using the same |
08/09/2007 | CA2640423A1 Nogo receptor antagonists |
08/09/2007 | CA2640082A1 Double helical oligonucleotides interfering with mrna used as effective anticancer agent |
08/09/2007 | CA2640058A1 Oligomeric compounds and compositions for the use in modulation of micrornas |
08/09/2007 | CA2638908A1 Compositions and their uses directed to huntingtin |
08/09/2007 | CA2638779A1 Production of polysialic acid containing glyconjugates using a self-priming polysialyltransferase |
08/09/2007 | CA2637881A1 Production of a soluble native form of recombinant protein by the signal sequence and secretional enhancer |
08/09/2007 | CA2637818A1 Expression system |
08/09/2007 | CA2637678A1 Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same |
08/09/2007 | CA2635964A1 Brittle stalk 2 gene family and related methods and uses |
08/09/2007 | CA2635722A1 Animal model for hiv induced disease |
08/09/2007 | CA2634286A1 Compositions and methods for regulating complement system |
08/09/2007 | CA2632657A1 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein |
08/09/2007 | CA2622679A1 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone |
08/08/2007 | EP1816216A2 Oligomer array with PNA and/or oligomers on a surface |
08/08/2007 | EP1816214A1 Methods and compositions for perioperative genomic profiling |
08/08/2007 | EP1816213A2 Novel DNA polymerase III holoenzyme delta subunit nucleic acid molecules and proteins |
08/08/2007 | EP1816207A1 Cell-free protein synthesis method with the use of linear template dna and cell extract therefor |
08/08/2007 | EP1816206A1 Method of producing uridine 5 -diphospho-n-acetylgalactosamine |
08/08/2007 | EP1816205A1 Serotype of adenovirus and uses thereof |
08/08/2007 | EP1816204A1 Recombinant Adenovirus of the Ad26 serotype |
08/08/2007 | EP1816203A1 An expression vector encoding coronavirus-like particles |
08/08/2007 | EP1816202A2 Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance |
08/08/2007 | EP1816201A1 Modified coagulation factor VIIa with extended half-life |
08/08/2007 | EP1816200A1 Postweaning multisystemic wasting syndrome virus for pigs |
08/08/2007 | EP1816199A1 Mutants of thyroid stimulating hormone and methods based thereon |
08/08/2007 | EP1816198A1 Variable fragments of immunoglobulins-use for therapeutic or veterinary purposes |
08/08/2007 | EP1816197A2 Method for synthesizing dna |
08/08/2007 | EP1816196A1 La1 - The genome of a Lactobacillus strain |
08/08/2007 | EP1816195A1 Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid |
08/08/2007 | EP1816194A1 Cancer-cell-specific proliferation inhibitors |
08/08/2007 | EP1816193A1 Lignan glycosidase and utilization of the same |
08/08/2007 | EP1816192A1 LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE |
08/08/2007 | EP1816191A1 METHOD OF SCREENING COMPOUND REGULATING THE TRANSLATION OF SPECIFIC mRNA |
08/08/2007 | EP1816140A1 Anti-glypican 3 antibody having modified sugar chain |
08/08/2007 | EP1816139A1 Nact as a target for lifespan expansion and weight reduction |
08/08/2007 | EP1816130A1 Novel nucleoside or nucleotide derivative and use thereof |